Quantcast

Latest Interferon beta-1a Stories

2009-10-19 12:06:00

ROCKLAND, Mass., Oct. 19 /PRNewswire/ -- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, marked the expansion of its research facility in Billerica, MA today, with a topping off ceremony.

2009-10-05 09:46:00

ROCKLAND, Mass., Oct. 5 /PRNewswire/ -- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that Science magazine has named it one of the world's leading biotechnology and pharmaceutical employers. EMD Serono's ranking improved to No. 6 this year, up from No.

2009-08-17 00:15:00

EAST HANOVER, N.J., Aug. 17 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease.

2009-06-19 00:17:31

Twenty-seven percent of multiple sclerosis patients are declining to fill their prescriptions, U.S.

2009-05-27 06:42:00

- New national survey reveals insights on treatment of disease, psychosocial burden, and delays in starting treatment ROCKLAND, Mass.

2009-04-15 08:46:00

Only 39 Percent of Newly Diagnosed Patients Receive a Drug Within One Year of Their First Diagnosis, According to a New Report from Decision Resources WALTHAM, Mass., April 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that surveyed neurologists anticipate that less than 30 percent of their use of emerging oral agents --- Merck Serono's oral cladribine, Novartis/Mitsubishi Pharma's...


Word of the Day
begunk
  • To befool; deceive; balk; jilt.
  • An illusion; a trick; a cheat.
The word 'begunk' may come from a nasalised variant of Scots begeck ("to deceive, disappoint"), equivalent to be- +‎ geck.